PMC:7402624 / 54783-55351
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T452 | 166-171 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T453 | 289-294 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T454 | 321-323 | Body_part | denotes | PB | http://purl.org/sig/ont/fma/fma84371 |
T455 | 360-364 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T456 | 394-398 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T457 | 420-422 | Body_part | denotes | PB | http://purl.org/sig/ont/fma/fma84371 |
T458 | 436-441 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T459 | 492-502 | Body_part | denotes | lymphocyte | http://purl.org/sig/ont/fma/fma62863 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1764 | 160-163 | Gene | denotes | CD4 | Gene:920 |
1765 | 283-286 | Gene | denotes | CD8 | Gene:925 |
1766 | 314-319 | Gene | denotes | T-bet | Gene:30009 |
1767 | 354-357 | Gene | denotes | CD8 | Gene:925 |
1768 | 388-391 | Gene | denotes | CD4 | Gene:920 |
1778 | 83-91 | Species | denotes | patients | Tax:9606 |
1779 | 107-115 | Species | denotes | patients | Tax:9606 |
1789 | 74-82 | Disease | denotes | COVID-19 | MESH:C000657245 |
1790 | 515-524 | Disease | denotes | infection | MESH:D007239 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T373 | 74-82 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T374 | 321-323 | Disease | denotes | PB | http://purl.obolibrary.org/obo/MONDO_0019035 |
T375 | 420-422 | Disease | denotes | PB | http://purl.obolibrary.org/obo/MONDO_0019035 |
T376 | 515-524 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T829 | 128-138 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
T830 | 160-163 | http://purl.obolibrary.org/obo/PR_000001004 | denotes | CD4 |
T831 | 164-171 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T cells |
T832 | 217-227 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
T833 | 260-269 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activated |
T834 | 283-286 | http://purl.obolibrary.org/obo/CLO_0053438 | denotes | CD8 |
T835 | 287-294 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T cells |
T836 | 299-300 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T837 | 354-357 | http://purl.obolibrary.org/obo/CLO_0053438 | denotes | CD8 |
T838 | 358-364 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T cell |
T839 | 388-391 | http://purl.obolibrary.org/obo/PR_000001004 | denotes | CD4 |
T840 | 392-398 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T cell |
T841 | 434-441 | http://purl.obolibrary.org/obo/CL_0000236 | denotes | B cells |
T842 | 537-538 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T843 | 557-567 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T60468 | 321-323 | Chemical | denotes | PB | http://purl.obolibrary.org/obo/CHEBI_53319|http://purl.obolibrary.org/obo/CHEBI_60686 |
T13552 | 340-348 | Chemical | denotes | effector | http://purl.obolibrary.org/obo/CHEBI_35224 |
T70633 | 420-422 | Chemical | denotes | PB | http://purl.obolibrary.org/obo/CHEBI_53319|http://purl.obolibrary.org/obo/CHEBI_60686 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T106 | 427-433 | http://purl.obolibrary.org/obo/GO_0007613 | denotes | memory |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T318 | 0-568 | Sentence | denotes | By deep immune profiling, we identified three immunotypes in hospitalized COVID-19 patients including: (1) patients with robust activation and proliferation of CD4 T cells, relative lack of cTfh, together with modest activation of TEMRA-like as well as highly activated or exhausted CD8 T cells and a signature of T-bet+ PB; (2) Tbetbright effector-like CD8 T cell responses, less robust CD4 T cell responses, and Ki67+ PB and memory B cells; and (3) an immunotype largely lacking detectable lymphocyte response to infection, suggesting a failure of immune activation. |